On 2026-02-27, CG Oncology, Inc. (CGON) announced earnings per share of $-0.51 for the fiscal quarter ending 2025-12-31, beating the average analyst estimate of $-0.61.
The next expected annoucement date for quarterly earnings is 2026-05-12, with an average estimated earnings per share of $-0.58 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-02-27 | 2025-12-31 | $-0.61 | $-0.51 |
| 2025-11-14 | 2025-09-30 | $-0.57 | $-0.57 |
| 2025-08-08 | 2025-06-30 | $-0.49 | $-0.54 |
| 2025-05-13 | 2025-03-31 | $-0.39 | $-0.45 |
| 2025-03-28 | 2024-12-31 | $-0.41 | $-0.48 |
| 2024-11-12 | 2024-09-30 | $-0.42 | $-0.30 |
| 2024-08-08 | 2024-06-30 | $-0.42 | $-0.28 |
| 2024-05-09 | 2024-03-31 | $-0.35 | $-0.36 |